Community Pharmacy England (CPE) - News updates

MHRA Class 2 Medicines Recall: Ramipril 5mg capsules (Crescent Pharma Limited) Drug alert number: EL(26)A/11 Date issued: 06 March 2026 Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site. DMRC reference number: DMRC-38717889 Company name: Crescent Pharma Limited Medicine Details [...] The post MHRA Class 2 Medicines Recall: Ramipril 5mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.

The final list of price concessions granted for February 2026 includes 174 lines. This is the highest number of concessions granted since March 2023. Drug price concessions hit three-year high | The Pharmaceutical Journal Our Director of Research and Insights, Dr. James Davies, said: “It has been a very worrying start to 2026 – with [...] The post Most price concessions granted since March 2023 appeared first on Community Pharmacy England.

Community pharmacies received strong backing yesterday in Parliament, with several MPs speaking out in support of the sector, recognising their vital role in community healthcare and raising concerns about an increasing trend of pharmacy closures. Discussions during the Parliamentary debate, which focussed on ‘Healthcare in Rural Areas’, emphasised that pharmacies are essential for providing accessible [...] The post MPs highlight valuable role of community pharmacy in Parliament appeared first on Community Pharmacy England.

Update 05/03/2026:  Propranolol 80mg modified release capsules are out of stock until July 2026 Propranolol 160mg modified release capsules are out of stock until July 2026 The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Propranolol 80mg modified release capsules Propranolol 160mg modified release capsules MSN/2025/059 [...] The post Medicine Supply Notification: Propranolol 80mg and 160mg modified release capsules – Updated appeared first on Community Pharmacy England.

The following price concessions granted in February 2026 have rolled over to March 2026: Drug  Pack size Price concession Quinine sulfate 300mg tablets 28 £2.01 Venlafaxine 37.5mg tablets 56 £2.60 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to indicate suppliers’ selling prices have increased. The [...] The post Rolled Over Price Concessions For March 2026 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (03/03/2026) confirmed the following final list of price concessions for February 2026: Drug Pack size Price concession Aqueous cream 100 £0.99 Aqueous cream 500 £5.80 Clarithromycin 125mg/5ml oral suspension 70 £11.10 (previously £9.59) Lofepramine 70mg tablets 56 £24.86 (previously £23.89) Trimethoprim 100mg tablets 28 £4.07 (previously [...] The post February 2026 Price Concessions Final Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has entered consultation with Community Pharmacy England on the 2026/27 Community Pharmacy Contractual Framework (CPCF). A letter signalling the start of the formal negotiations process was sent to Community Pharmacy England this week. Detailed discussions begin immediately and will cover funding, service changes and other arrangements for [...] The post Negotiations on 2026/27 Contractual Framework commence appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (27/02/2026) confirmed the following list of price concessions for February 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.  [...] The post February 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

From 1 June 2026, the Manage Your Service (MYS) will be the only route to notify ICBs of temporary suspensions/closures. This week, NHS England announced that it was giving advance notice of changes to the approved manner of reporting temporary suspensions of service or likely temporary suspensions of service (temporary closures) to ICBs. The changes [...] The post Changes to the reporting of Temporary Suspensions appeared first on Community Pharmacy England.

Community Pharmacy England is taking steps to tackle inappropriate EPS pharmacy nomination practices and service direction, which contravene the principles of patient choice. Since concerns around certain IT functionality allowing automatic re-nomination (without patient consent) and the direction of services were first raised last year, our Regulatory and IT experts have been working to address [...] The post Clamping down on inappropriate EPS nomination and service direction appeared first on Community Pharmacy England.